companydata.dkBILLEV PHARMA ApS: Financial statements 2022
CVR: 81814813
BILLEV PHARMA ApS (CVR 81814813) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 30,170,800 and a net result of DKK 6,013,157 compared with DKK 5,548,863 the year before. That is an increase of 17.7% compared with the year before. Equity amounted to DKK 6,333,157. The solvency ratio was 61.1%. The company had 21 employees in the financial year.
- Gross Profit
- 30,170,800 kr.
- Profit/Loss
- 6,013,157 kr.
- Equity
- 6,333,157 kr.
- Total Assets
- 10,361,535 kr.
- Employees
- 21
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 30.2 mio. | 6 mio. | 6.3 mio. | 21 |
| 2021 | - | 25.6 mio. | 5.5 mio. | 5.9 mio. | 19 |
| 2020 | - | 21.4 mio. | 3.8 mio. | 4.1 mio. | 16 |
| 2019 | - | 17.5 mio. | 2.5 mio. | 2.8 mio. | 14 |
| 2018 | - | 17.1 mio. | 3.7 mio. | 4 mio. | 13 |
Keep an eye on BILLEV PHARMA ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringAbout BILLEV PHARMA ApS
BILLEV PHARMA ApS is a Danish company of the type Anpartsselskab based in Hørsholm, founded in 1977. The company is registered under the industry Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.. The management consists of Ulrikke Lynge Jensen and Anja Wencke van Arkens. The company is owned by VAN ARKENS HOLDING ApS and UL JENSEN HOLDING ApS. The company has 15 employees. In 2026, the company reported a gross profit of DKK 38,801,270 and a net result of DKK 10,205,639 compared with DKK 6,143,854 the year before. Equity amounted to DKK 10,525,639.